Replimune competitors and similar companiesClear all

Replimune's competitors and similar companies include 3sbio, Kyowa Kirin, Acerta Pharma and Clovis Oncology.
Replimune
Replimune
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Acerta Pharma
Acerta Pharma
Acerta Pharma is a biopharmaceutical company.
Clovis Oncology
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Founding Date
Founding Date
2015
Founding Date
1993
Founding Date
2008
Founding Date
2013
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Woburn, US HQ
Milton, GB
Woburn, US
Locations
Shenyang, CN HQ
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Locations
South San Francisco, US HQ
Oss, NL
Oss, NL
Locations
Boulder, US HQ
Paris, FR
München, DE
Dublin, IE
Milano, IT
Madrid, ES
Zürich, CH
see more
Employees
Employees
10422% increase
Employees
5,2325% decrease
Employees
5,752
Employees
197
Employees
4843% increase
Valuation ($)
Valuation ($)
1.3 b
Valuation ($)
N/A
Valuation ($)
12 b
Valuation ($)
N/A
Valuation ($)
10.6 m
Alexa Website Rank
Alexa Website Rank
415014
Alexa Website Rank
416661
Alexa Website Rank
398341
Alexa Website Rank
639575
Alexa Website Rank
495033
Employee Rating
Employee Rating
3.3
Employee Rating
3
Employee Rating
N/A
Employee Rating
3.5
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥6.4b (FY, 2021)
Revenue (est.)
¥352.2b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$148.8m (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
¥777.3m (FY, 2021)
Cost of goods
¥78.9b (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥5.7b (FY, 2021)
Gross profit
¥274.7b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($118m) (FY, 2022)
Net income
¥1.6b (FY, 2021)
Net income
¥52.3b (FY, 2021)
Net income
N/A
Net income
($264.5m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 30m
Total funding raised
$ 15.2m
Total funding raised
N/A
Total funding raised
$ 60m
Total funding raised
$ 357m
For sources of this data, please see the company profile

View company profiles

3sbio
HQ
Shenyang, CN
Employees
5,232↓ 5% decrease

3sbio (三生制药集团) is a company that develops biopharmaceuticals.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,752

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company
Acerta Pharma
HQ
South San Francisco, US

Acerta Pharma is a biopharmaceutical company.

View company
Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company